Bio-Techne (TECH) Accumulated Depreciation & Amortization (2010 - 2026)

Bio-Techne has reported Accumulated Depreciation & Amortization for 17 years, with the latest figure at $300.8 million in Q1 2026.

• For the quarter ending Q1 2026, Accumulated Depreciation & Amortization rose 7.9% year-over-year to $300.8 million; the trailing twelve-month figure through Mar 2026 stood at $300.8 million (up 7.9% YoY), and the FY2025 full-year result was $286.1 million, up 11.53% from the prior year.
• Accumulated Depreciation & Amortization for Q1 2026 stood at $300.8 million, up from $293.1 million in the prior quarter.
• The five-year high for Accumulated Depreciation & Amortization was $300.8 million in Q1 2026, with the low at $206.8 million in Q1 2022.
• Average Accumulated Depreciation & Amortization over 5 years is $252.9 million, with a median of $251.9 million recorded in 2024.
• Year-over-year, Accumulated Depreciation & Amortization grew 11.59% in 2023 and rose 7.9% in 2026.
• Tracing TECH's Accumulated Depreciation & Amortization over 5 years: stood at $223.3 million in 2022, then grew by 9.79% to $245.2 million in 2023, then gained by 10.24% to $270.3 million in 2024, then climbed by 8.43% to $293.1 million in 2025, then rose by 2.63% to $300.8 million in 2026.
• The last three Accumulated Depreciation & Amortization figures came in at $300.8 million (Q1 2026), $293.1 million (Q4 2025), and $289.0 million (Q3 2025), per Business Quant data.

Peer Comparison